PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,469 | -29.6% | 4,292 | -18.9% | 0.00% | – |
| Q1 2023 | $13,456 | +34.2% | 5,292 | -0.3% | 0.00% | – |
| Q4 2022 | $10,030 | -22.8% | 5,308 | +10.8% | 0.00% | – |
| Q3 2022 | $13,000 | +44.4% | 4,792 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 4,792 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -39.1% | 4,792 | -9.4% | 0.00% | – |
| Q4 2021 | $23,000 | -57.4% | 5,292 | -53.2% | 0.00% | – |
| Q3 2021 | $54,000 | -41.9% | 11,310 | -16.2% | 0.00% | – |
| Q2 2021 | $93,000 | -22.5% | 13,490 | -19.8% | 0.00% | – |
| Q1 2021 | $120,000 | +16.5% | 16,820 | +2.4% | 0.00% | – |
| Q4 2020 | $103,000 | +145.2% | 16,420 | +109.7% | 0.00% | – |
| Q3 2020 | $42,000 | +10.5% | 7,830 | +9.8% | 0.00% | – |
| Q2 2020 | $38,000 | +65.2% | 7,130 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 7,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
| Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
| Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
| Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
| Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
| Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
| 1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
| CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
| Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
| GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |